As of Wednesday, February 18, Canopy Growth Corporation’s CGC share price has surged by 6.38%, which has investors questioning if this is right time to sell.
In a Feb. 10 note, Kirk reiterated his “Buy” rating on Canopy but lowered his price target to C$5.00 from C$8.00 ...
Zacks Investment Research on MSN
Canopy Growth Corporation (CGC) is a trending stock: Facts to know before betting on it
Canopy Growth Corporation (CGC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...
Canopy Growth recently reported improved financial performance for Q4-2024. Canopy USA has acquired US THC cannabis assets and plans to acquire more. The company expects an increase in demand for its ...
Canopy says revenue from international cannabis markets increased 32% year-over-year to $12 million, driven by growth in Germany and Poland. Canopy's Canada medical cannabis segment delivered a fifth ...
Sometimes, you need to know when to quit.
Canopy Growth announces an at-the-market equity program, allowing it to issue and sell up to $250 million worth of its common stock. The net proceeds may be used for investments in businesses or to ...
The cannabis company's shares have plummeted by more than 40% over the past year.
Canadian cannabis company Canopy Growth (NASDAQ: CGC) tumbled 9.8% through 11:55 a.m. ET Thursday after announcing plans to create and sell $250 million new Canopy shares at whatever the market price ...
Canopy Growth Corporation (CGC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results